(Q53062089)

11 May 2018

title

Mucosal delivery of antigens using adsorption to bacterial spores. (English)

1 reference

11 May 2018

3

Hoang Van Tong

1 reference

11 May 2018

author name string

Jen-Min Huang

1

1 reference

11 May 2018

Huynh A Hong

2

1 reference

11 May 2018

Tran H Hoang

4

1 reference

11 May 2018

Alain Brisson

5

1 reference

11 May 2018

Simon M Cutting

6

1 reference

11 May 2018

language of work or name

English

0 references

publication date

13 November 2009

1 reference

11 May 2018

published in

Vaccine

1 reference

11 May 2018

volume

28

1 reference

11 May 2018

issue

4

1 reference

11 May 2018

page(s)

1021-1030

1 reference

11 May 2018

Live bacterial vaccines--a review and identification of potential hazards

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Recombinant liveSalmonellaspp. for human vaccination against heterologous pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

The use of bacterial spore formers as probiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Bacterial spores as vaccine vehicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Mucosal immunisation: adjuvants and delivery systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Overview of vaccine adjuvants: present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Oral priming of mice by recombinant spores of Bacillus subtilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Bacillus subtilis spores: a novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

The intestinal life cycle of Bacillus subtilis and close relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Surface display of recombinant proteins on Bacillus subtilis spores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Recovery of spores from thermophilic dairy bacilli and effects of their surface characteristics on attachment to different surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Biochemical properties of cloned glutathione S-transferases from Schistosoma mansoni and Schistosoma japonicum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Screening for bacillus isolates in the broiler gastrointestinal tract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Influence of electrical properties on the evaluation of the surface hydrophobicity of Bacillus subtilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Germination-independent induction of cellular immune response by Bacillus subtilis spores displaying the C fragment of the tetanus toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Fully mobilizing host defense: building better vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Structure, assembly, and function of the spore surface layers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Ruthenium red staining for ultrastructural visualization of a glycoprotein layer surrounding the spore of Bacillus anthracis and Bacillus subtilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Bacillus subtilis isolated from the human gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

A laboratory study of bacteria-facilitated cadmium transport in alluvial gravel aquifer media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

inferred from DOI database lookup

7 January 2021

based on heuristic

Surface Charge Properties of and Cu(II) Adsorption by Spores of the Marine Bacillus sp. Strain SG-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.127

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.10.127

1 reference

11 May 2018

1 reference

11 May 2018